Alembic Pharmaceuticals Ltd
Swapnil Patil is an experienced professional in the pharmaceutical industry, currently serving as an Executive at Alembic Pharmaceuticals Limited since October 2022. Prior to this role, Swapnil worked in Quality Control at Glenmark Pharmaceuticals Ltd. from September 2016 to September 2022. Swapnil holds a Master of Science degree in Organic Chemistry, obtained from SSVPS'S Late Karmaveer Dr. P.R. Ghogrey Science College in Dhule, where studies were completed from 2014 to 2016.
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
9 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.